Pr ecis: These provocative findings show how depriving androgen-dependent prostate cancer cells of androgen not only compromises cell survival, but also helps create a nonmalignant neuroendocrine phenotype in surviving cells that can ultimately support the outgrowth of androgenindependent tumors.
Pr ecis: This article offers a systematic definition of the entire metastasis-associated miRNA landscape using an unbiased profiling approach of metastasis tissues from patients. Pr ecis: This conceptually powerful study illuminates how the effects of oncogene activation extend beyond wellstudied cell autonomous roles in proliferation, apoptosis, and invasion to suppressive effects on the local immune microenvironment, which are essential to license immune escape as the critical step in tumorigenesis.
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Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity Pr ecis: This study describes new mouse models for temporal dissociation of genetic events in lung carcinogenesis and establishes a core role for the p53 pathway in restricting lung cancer development.
3181
Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma
Tao Li, Junjie Xie, Chuan Shen, Dongfeng Cheng, Yuan Shi, Zhichong Wu, Xiaxing Deng, Hao Chen, Baiyong Shen, Chenghong Peng, Hongwei Li, Qian Zhan, and Zhecheng Zhu Pr ecis: These findings illuminate the oncogenic function of a noncoding RNA that acts by opposing tumor-suppressive effects of miR-150, suggesting utility as a prognostic biomarker or target for clinical management of HCC.
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ABOUT THE COVER
The immunofluorescence image is of an aortic ring treated with IL6 stained for vessels (green), pericytes (red), and cell nuclei (blue). Here, it is shown that IL6 stimulates angiogenesis with defective pericyte coverage. Treatment of peritoneal xenografts of ovarian cancer with an anti-IL6 antibody restored pericyte coverage of the tumor blood vessels. The authors' findings have implications for the use of cancer therapies that target IL6 and for understanding abnormal angiogenesis in cancers, chronic inflammatory disease, and stroke. For details, see article by Gopinathan and colleagues on page 3098. To request permission to re-use all or part of this article, contact the AACR Publications Department at
